These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8380922)

  • 1. 'W' mutant forms of the Fms receptor tyrosine kinase act in a dominant manner to suppress CSF-1 dependent cellular transformation.
    Reith AD; Ellis C; Maroc N; Pawson T; Bernstein A; Dubreuil P
    Oncogene; 1993 Jan; 8(1):45-53. PubMed ID: 8380922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fms gene and the CSF-1 receptor.
    Sherr CJ; Rettenmier CW
    Cancer Surv; 1986; 5(2):221-32. PubMed ID: 3022923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming activities of human CSF-1 receptors with different point mutations at codon 301 in their extracellular domains.
    Roussel MF; Downing JR; Sherr CJ
    Oncogene; 1990 Jan; 5(1):25-30. PubMed ID: 2157180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming potential of the c-fms proto-oncogene (CSF-1 receptor).
    Roussel MF; Dull TJ; Rettenmier CW; Ralph P; Ullrich A; Sherr CJ
    Nature; 1987 Feb 5-11; 325(6104):549-52. PubMed ID: 3027579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel 110 kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling.
    Cross M; Csar XF; Wilson NJ; Manes G; Addona TA; Marks DC; Whitty GA; Ashman K; Hamilton JA
    Biochem J; 2004 May; 380(Pt 1):243-53. PubMed ID: 14969583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cell cycle entry and G1 progression by CSF-1.
    Roussel MF
    Mol Reprod Dev; 1997 Jan; 46(1):11-8. PubMed ID: 8981358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of urokinase plasminogen activator gene transcription in the RAW264 murine macrophage cell line by macrophage colony-stimulating factor (CSF-1) is dependent upon the level of cell-surface receptor.
    Fowles LF; Stacey KJ; Marks D; Hamilton JA; Hume DA
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):313-20. PubMed ID: 10727433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements for transformation by the fms oncogene product (CSF-1 receptor).
    Rettenmier CW; Roussel MF; Wheeler EF; Sherr CJ
    Princess Takamatsu Symp; 1986; 17():211-8. PubMed ID: 2843495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of all-trans-retinoic acid on c-fms proto-oncogene [colony-stimulating factor 1 (CSF-1) receptor] expression and CSF-1-induced invasion and anchorage-independent growth of human breast carcinoma cells.
    Sapi E; Flick MB; Tartaro K; Kim S; Rakhlin Y; Rodov S; Kacinski BM
    Cancer Res; 1999 Nov; 59(21):5578-85. PubMed ID: 10554038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of activating mutations of c-fms in FDC-P1 cells.
    Glover HR; Baker DA; Celetti A; Dibb NJ
    Oncogene; 1995 Oct; 11(7):1347-56. PubMed ID: 7478556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts.
    Insogna K; Tanaka S; Neff L; Horne W; Levy J; Baron R
    Mol Reprod Dev; 1997 Jan; 46(1):104-8. PubMed ID: 8981371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of phosphatidylinositol 3-kinase is necessary for differentiation of FDC-P1 cells following stimulation of type III receptor tyrosine kinases.
    Kubota Y; Angelotti T; Niederfellner G; Herbst R; Ullrich A
    Cell Growth Differ; 1998 Mar; 9(3):247-56. PubMed ID: 9543391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the CSF-1 receptor gene (C-fms) in cell transformation.
    Sherr CJ
    Leukemia; 1988 Dec; 2(12 Suppl):132S-142S. PubMed ID: 2848991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance.
    Taylor JR; Brownlow N; Domin J; Dibb NJ
    Oncogene; 2006 Jan; 25(1):147-51. PubMed ID: 16170366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cAMP inhibits CSF-1-stimulated tyrosine phosphorylation but augments CSF-1R-mediated macrophage differentiation and ERK activation.
    Wilson NJ; Cross M; Nguyen T; Hamilton JA
    FEBS J; 2005 Aug; 272(16):4141-52. PubMed ID: 16098196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
    Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colony-stimulating factor-1 receptor (c-fms).
    Sherr CJ; Roussel MF; Rettenmier CW
    J Cell Biochem; 1988 Nov; 38(3):179-87. PubMed ID: 2852667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation by the v-fms oncogene product: an analog of the CSF-1 receptor.
    Rettenmier CW; Jackowski S; Rock CO; Roussel MF; Sherr CJ
    J Cell Biochem; 1987 Feb; 33(2):109-15. PubMed ID: 3032997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
    Danielsen AJ; Maihle NJ
    Exp Cell Res; 2002 Apr; 275(1):9-16. PubMed ID: 11925101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.